CoChat

Immunotherapy for Alzheimer’s disease

· 2005 · Alzheimer's Disease and Related Disorders
Cited by 65

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

One of the most long-standing debates in Alzheimer’s disease (AD) research concerns the relative importance, or the relative temporal relationships, of βamyloid plaques and abnormally phosphorylated tau proteins, both of which are seen as histopathologic hallmarks of the disease. At present the pendulum has swung towards amyloid being the main protagonist. The amyloid cascade hypothesis states that overproduction, decreased clearance, or enhanced aggregation of the amyloid β-42 protein (Aβ42) derived from an abnormal cleavage of the transmembranous amyloid precursor protein (APP) results in a cascade of events, culminating in cell death and dementia (Figure 5.1). A number of strategies are being explored as ways of preventing the oligomerization and aggregation of Aβ42 or of increasing its removal from the CNS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1201/b13935-7

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 65

Metadata

Venue
Alzheimer's Disease and Related Disorders
Publisher
CRC Press
Published
2005-09-22
Pages
83-98
OpenAlex
W2363821006
Cited by
65
References
1
FWCI
13.78
Type
book chapter
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Immunotherapy for Alzheimer’s disease. https://app.cochat.ai/papers/10.1201/b13935-7
The paper
Immunotherapy for Alzheimer’s disease. (2005). Alzheimer's Disease and Related Disorders. https://doi.org/10.1201/b13935-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.